Near-patient testing, particularly for glucose and cholesterol, has been with us for a number of years in general practice. Various recommendations have been made throughout the years regarding how this procedure should be carried out, who should be involved and how quality should be assessed."" Most methods for glucose and cholesterol involve dry strip chemistries and involve the operator in some type of sample volume measurement with the exception of the Abbott Vision (Abbott Diagnostics Division, Maidenhead, UK) and the Biomen Spotchem (Biomen Ltd, Wokingham, UK). Most of the recommendations cited above suggest the use of both internal and external quality assurance procedures, but often internal quality assurance is difficult to achieve. This is partly because most of the materials are lyophilized and require reconstitution and there may be a lack of deep freeze facilities available within the practice and a reluctance to purchase one of these solely for the use of this single test procedure. It is hazardous and against health and safety regulations to store biological quality control materials in either the staff foodstuff refrigerator or in the pharmacy refrigerator. On the other hand external quality control procedures usually involve significant laboratory resource in sample preparation and distribution, collation of results and report preparation. This report presents a different way of retrospectively providing external quality control for cold, non-acute tests in general practice.
METHODS AND RESULTS
A local rural general practice purchased an instrument capable of measuring cholesterol and other analytes from locally raised charitable funds.
568
Cholesterol testing was to be used to screen the population. This was easier to carry out using an instrument within the practice than using laboratory services at some distance. The instrument selected with advice from the laboratory was the Biomen Spotchem and the practice agreed that the laboratory would help in training staff, quality control procedures and calibration of the instrument. The practice was reluctant to buy a deep freeze simply to store internal quality control materials and also reluctant to release funds to join a commercial external quality assurance scheme.
As a compromise it was suggested that the following procedure was adopted for cholesterol testing. Any result > 6· 5 mmol/L on the screening method would be followed up by a repeat sample to be sent to the laboratory which would also request the tests to exclude secondary causes of hyperlipidaemia (glucose, thyroid function and liver function tests). The expected number of patients was approximately six per week and it was agreed that on a regular weekly basis one or two patient samples from the same venepuncture would be referred to the laboratory for repeat analysis. In fact, on average, seven samples were measured each week and the instrument was not used every day, only once or twice a week and not every week. The samples for local testing were transferred into small lithium heparin tubes mixed and centrifuged using the Spotchem centrifuge. The remaining clotted sample was sent in the usual way to the laboratory. This procedure was fully verified in the laboratory before being instigated in the practice. These samples arrived in the laboratory in the usual way but included the practice cholesterol result from the same sample. The sample was then processed through the laboratory in the normal way and drawn to the attention of a senior member of staff who made an appropriate comment as to whether the results were within clinically acceptable limits of 
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throughput screening 'near-patient testing' when non-acute results are being obtained. It shows that the analytical procedure using Spotchem, with a number of different batches of strips and the appropriate number of calibrations, is a very stable procedure with no significant bias compared with the laboratory results. Although this quality assurance procedure does not meet with the full recommendations of the guidelines recently published] it may be one of the best compromises that can be achieved in some circumstances.
CONCLUSION
one another. A report was then generated with a comment as to whether or not the Spotchem should continue to be used or whether activity should be suspended until the laboratory visited the practice to rectify any potential problem. The laboratory visited on a regular basis (approximately monthly) and carried out quality control checks and evaluation of the performance of the instrument using the manufacturer's calibration check material which comes with quoted values. The manufacturer cooperated fully with the wishes of the laboratory-leaving training and quality assurance matters to the laboratory but providing full service support and agreeing to calibrate the instrument when new batches of strips were supplied. Figure 1 shows practice results alongside the laboratory results for each of the samples analysed and also the difference between the results. Only on two occasions were the differences > 1 mmol/L, both when the patient results were in the 6-8 mmol/L range. On each occasion the result instigated a cessation of activity as well as a visit from laboratory staff to check instrument performance. This delta range was agreed at the beginning of the study; perhaps with hindsight a percentage difference might have been more appropriate. Whenever a cessation of activity was requested the agreement from the practice involved recall of all the patients who had attended since the last time adequate performance was displayed. This involved three or four patients on the two occasions. In both of the out of control situations a member of laboratory staff visited the practice to examine the instrument and talk to nursing staff who had undertaken the measurements. On one occasion, the batch of strips had been changed without recalibration but on the other occasion no reason could be found for the differences noted. On each occasion, the instrument was cleaned and checked using the calibrator check material. During the study period samples from 590 patients were measured: 57 values (lOO7o) were > 7· 8 mmol/L; 122 (210J0) between 6·5 and 7·8 mmol/L; and 196 (330J0) between 5· 2 and 6· 4 mmol/L. This very simple external quality assurance procedure appears to work very well for low Accepted for publication 3 May 1994 
